Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement
Launched by HADASSAH MEDICAL ORGANIZATION · Mar 24, 2021
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of cannabis oil on people experiencing acute radicular back pain, which is a type of pain that radiates along a nerve due to irritation or injury. The researchers want to see if a combination of two compounds found in cannabis—THC (the compound that can cause a "high") and CBD (which does not)—can help reduce pain and lower the need for other pain medications. While there is some evidence suggesting cannabis may be helpful for acute pain, the results from previous studies have been mixed. This trial aims to provide clearer information on its effectiveness.
To participate in the trial, individuals must be between 18 and 70 years old and have been experiencing moderate to severe radicular pain for less than 12 weeks. However, those with certain health conditions, a history of regular cannabis or opioid use, or who are pregnant or breastfeeding cannot join. Participants will receive the cannabis oil and will be monitored throughout the study to assess how well it works and if there are any side effects. This trial is currently recruiting and offers a potential new option for managing acute pain for those who qualify.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 - 70 years
- • ASA 1 or 2
- • Acute Radicular Pain \< 12 weeks
- • Pain of VAS 6 or more/ VRS moderate or more
- • Radicular pain: Dermatomal pain that corresponds to physical exam and CT/MRI in the last year
- Exclusion Criteria:
- • Age \< 18 or \> 70 years
- • ASA 3 or more
- • Chronic radicular pain \> 12 weeks
- • Past spine surgery
- • Intermittent Claudication due to Vascular Disease
- • Diagnosed Diabetic Neuropathy
- • Regular Cannabis use in past 6 months (more than once a week) OR once in last 2 weeks
- • Regular opioid use in past week (Targin, Percocet, Tramadol) (Equivalent to Oxycodone 20 mg/day or more)
- • Pregnancy or Lactating
- • Ischemic heart disease
- • Renal or hepatic failure
- • History of psychiatric illness
- • Cognitive impairment or inability to answer questions
- • Known allergy to opioids
- • Potential Loss to follow up
About Hadassah Medical Organization
Hadassah Medical Organization (HMO) is a leading healthcare institution based in Jerusalem, Israel, renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, HMO leverages its state-of-the-art facilities and multidisciplinary expertise to conduct innovative research across various therapeutic areas. The organization is dedicated to fostering collaboration between clinical researchers, healthcare professionals, and academic institutions, ensuring the highest standards of ethical practice and scientific rigor. HMO's mission is to translate groundbreaking research into effective treatments, ultimately enhancing health outcomes for diverse populations both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jerusalem, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials